AstraZeneca PLC Ordinary Shares
AZN · US · Pharma & Biotech · $163 a share (close of 15 Sep 2026)
Available company data, source links and archived checks for AstraZeneca PLC Ordinary Shares. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Who holds it — from the filings
Jupiter Topco LLCRA CAPITAL MANAGEMENT, L.P.BlackRock, Inc.DEERFIELD MANAGEMENT COMPANY, L.P.Saturn V Capital Management LPregister as filed
2026-08-31
Filing timeline — what the company told the exchange
- 6-K
1
a4455v.htm
KLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuan…
21 Sep 2026 · document
- 6-K
1
a4447v.htm
ENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
…
21 Sep 2026 · document
- 6-K
1
a2662v.htm
DIRECTOR/PDMR SHAREHOLDING
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 …
18 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time